Expert NetworkExpert InterviewTGTX

Slingshot members are talking to an expert! The topic is:

Getting a prescriber's perspective comparing Briumvi, Ocrevus and Kesimpta in treating multiple sclerosis

Executed on:Oct 3, 2023 6:00 PM EDT
Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert
Institution: The Boster Center for Multiple Sclerosis
  • Founder, The Boster Center for Multiple Sclerosis.
  • Manages 1400 patients with Multiple Sclerosis and has prescribed Ocrevus, Kesimpta and Briumvi.
  • Principal investigator in numerous Clinical Trials and published extensively in medical journals.

    Interview Goal

    This call will focus on understanding the present and future usage of anti-CD20 drugs, specifically on the current use of Briumvi, Kesimpta and Ocrevus.

    Slingshot Insights Explained

    Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.